Luyan Pharma Co., Ltd. (002788) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Luyan Pharma Co., Ltd.

Why is Luyan Pharma Co., Ltd. ?

The company is Net-Debt Free

Poor long term growth as Net Sales has grown by an annual rate of 5.57% and Operating profit at -0.14% over the last 5 years
The company is Net-Debt Free
The company has been able to generate a Return on Equity (avg) of 11.96% signifying low profitability per unit of shareholders funds

Poor long term growth as Net Sales has grown by an annual rate of 5.57% and Operating profit at -0.14% over the last 5 years

Flat results in Mar 26

OPERATING CASH FLOW(Y) Lowest at CNY 519.76 MM
ROCE(HY) Lowest at 8.4%

With ROE of 8.16%, it has a very expensive valuation with a 1.28 Price to Book Value

Over the past year, while the stock has generated a return of 40.24%, its profits have fallen by -17.6%
At the current price, the company has a high dividend yield of 3.1

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Retailing)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Luyan Pharma Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Luyan Pharma Co., Ltd.

40.24%

0.72

61.23%

China Shanghai Composite

21.43%

1.55

13.83%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

5.57%

EBIT Growth (5y)

-0.14%

EBIT to Interest (avg)

3.24

Debt to EBITDA (avg)

6.98

Net Debt to Equity (avg)

1.87

Sales to Capital Employed (avg)

2.14

Tax Ratio

23.83%

Dividend Payout Ratio

48.41%

Pledged Shares

Institutional Holding

ROCE (avg)

8.02%

ROE (avg)

11.96%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.28

EV to EBIT

19.16

EV to EBITDA

16.96

EV to Capital Employed

1.10

EV to Sales

0.51

PEG Ratio

Dividend Yield

3.07%

ROCE (Latest)

5.72%

ROE (Latest)

8.16%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Bullish

RSI

Bearish

No Signal

Bollinger Bands

Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Bearish

Bullish

Dow Theory

Mildly Bearish

OBV

No Trend

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

2What is working for the Company

RAW MATERIAL COST(Y)

Fallen by -6.53% (YoY

CASH AND EQV(HY)

Highest at CNY 1,172.9 MM

-5What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at CNY 519.76 MM

ROCE(HY)

Lowest at 8.4%

Here's what is working for Luyan Pharma Co., Ltd.

Cash and Eqv

Highest at CNY 1,172.9 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is improving

Cash and Cash Equivalents

Raw Material Cost

Fallen by -6.53% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Luyan Pharma Co., Ltd.

Operating Cash Flow

Lowest at CNY 519.76 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)